Facts and promises on lung biomarkers in interstitial lung diseases

Ilaria Campo, Michele Zorzetto, Francesco Bonella

Research output: Contribution to journalArticle

Abstract

Interstitial lung diseases (ILDs) are a heterogeneous group of >100 pulmonary disorders. ILDs are characterized by an irreversible architectural distortion and impaired gas exchange; however, there is great variability in the clinical course. ILD diagnosis requires a combination of clinical data, radiological imaging and histological findings (when a lung biopsy is required). At the same time, successful management of ILD patients strictly depends on an accurate and confident diagnosis. In this context, the detection of reliable biomarkers able to identify ILD subtypes, avoiding lung biopsy, as well as the capacity to stratify patients and predict over time the disease course, has become a primary aim for all research studies in this field.

Original languageEnglish
Pages (from-to)437-457
Number of pages21
JournalExpert Review of Respiratory Medicine
Volume9
Issue number4
DOIs
Publication statusPublished - Aug 1 2015

    Fingerprint

Keywords

  • circulating biomarkers
  • epigenetics
  • genes
  • genome-wide analysis
  • interstitial lung disease
  • lung fibrosis
  • miRNAs

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy
  • Public Health, Environmental and Occupational Health

Cite this